Overview and Scope
Therapeutic BCG vaccine refers to a vaccine that offers defense against TB, also referred to as tuberculosis. The therapeutic BCG vaccine, which stands for the Bacillus Calmette-Guérin vaccine, is not a part of the standard NHS vaccination schedule. Only one dose of the BCG vaccine should be administered in a lifetime.
Sizing and Forecast
The therapeutic bcg vaccines market size has grown strongly in recent years. It will grow from $53.99 billion in 2023 to $57.14 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to government initiatives for tb control, immune system modulation, global immunization programs, treatment of bladder cancer, investments in vaccine manufacturing, emergence of drug-resistant tb strains..
The therapeutic bcg vaccines market size is expected to see strong growth in the next few years. It will grow to $72.54 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to expansion to other indications, increased research on immunotherapy, global efforts against emerging infectious diseases, regulatory support for vaccine development, focus on tuberculosis elimination.. Major trends in the forecast period include advancements in vaccine technology, supply chain optimization, market consolidation and partnerships, patient education and awareness, alternative delivery methods, personalized medicine approaches..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report
Segmentation & Regional Insights
The therapeutic bcg vaccines market covered in this report is segmented –
1) By Type: Therapy BCG, Immune BCG
2) By Demographics: Pediatrics, Adults
3) By End Use: Hospitals, Clinics, Other End Users
Top 5 Major Players:
- Merck & Co Inc.,
- Sanofi Pasteur,
- Japan BCG Laboratory,
- China National Biotec Group,
- Serum Institute of India Pvt. Ltd
Asia-Pacific was the largest region in the therapeutic BCG vaccines market in 2023. The regions covered in the therapeutic bcg vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9178&type=smp
Major Driver Impacting Market Growth
The rising number of tuberculosis (TB) cases worldwide will propel the growth of the therapeutic BCG vaccine market going forward. Tuberculosis (TB) is an infectious illness that can be potentially dangerous and primarily impacts the lungs. People can contract tuberculosis from one another by coughing or sneezing small droplets of bacteria into the air. BCG vaccines are used to stimulate the immune system to fight infection but do not cause TB since the germs are weak. It consistently offers protection against the most dangerous types of TB, such as adolescent TB meningitis. The BCG vaccine protects against tuberculosis which helps to fight against infection, hence the usage of therapeutic BCG vaccines increased. For instance, in October 2022, according to a report published by the World Health Organization, a specialized agency of the United Nations responsible for international public health, 10.6 million people were predicted to have contracted tuberculosis (TB) in 2021, an increase of 4.5% from 2020, and 1.6 million died from TB (including 187,000 HIV-positive individuals). Therefore, the rising number of tuberculosis (TB) cases worldwide is driving the growth of the therapeutic BCG vaccine market.
Key Industry Players
Major companies operating in the therapeutic BCG vaccine market are focused on innovating vaccines for potential therapeutic applications in various medical conditions, such as BCG immunotherapy, to expand their customer base and meet growing patient needs. BCG (Bacillus Calmette-Guérin) immunotherapy refers to the use of the BCG vaccine as a form of immunotherapy to treat certain types of cancer, particularly bladder cancer. For instance, in July 2023, The Serum Institute of India, an India-based biotechnology and biopharmaceuticals company, received government approval to export its BCG vaccine to Canada for immunotherapeutic use in treating bladder cancer. This live freeze-dried preparation, derived from an attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin), is intended for intravenous instillation. The vaccine is available in 40 mg and 80 mg presentations. As an integral part of the therapy, the vaccine is administered directly into the bladder through a catheter, where it remains in the bladder lining for a specified duration. This targeted approach aims to impact cancer cells effectively while minimizing impact on other parts of the body.
The therapeutic bcg vaccines market report table of contents includes:
1. Executive Summary
2. Therapeutic BCG Vaccines Market Characteristics
3. Therapeutic BCG Vaccines Market Trends And Strategies
4. Therapeutic BCG Vaccines Market – Macro Economic Scenario
5. Global Therapeutic BCG Vaccines Market Size and Growth
….
31. Global Therapeutic BCG Vaccines Market Competitive Benchmarking
32. Global Therapeutic BCG Vaccines Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Therapeutic BCG Vaccines Market
34. Therapeutic BCG Vaccines Market Future Outlook and Potential Analysis
35. Appendix
List of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
….
Table 74: Merck & Co Inc. Financial Performance
Table 75: Sanofi Pasteur Financial Performance
Table 76: Japan BCG Laboratory Financial Performance
Table 77: China National Biotec Group Financial Performance
Table 78: Serum Institute of India Pvt. Ltd. Financial Performance
Explore the trending research reports from TBRC:
https://topprnews.com/lewy-body-dementia-treatment-market-share/
https://topprnews.com/neurotechnology-market-share/
https://topprnews.com/nonmetallic-minerals-mining-support-activities-market-share/
https://goodprnews.com/lewy-body-dementia-treatment-market-share/
https://goodprnews.com/neurotechnology-market-share/
https://goodprnews.com/nonmetallic-minerals-mining-support-activities-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
